GÜRKAN, E. Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels. European Journal of Therapeutics, [S. l.], v. 26, n. 1, p. 76–80, 2023. DOI: 10.5152/eurjther.2020.19005. Disponível em: https://eurjther.com/index.php/home/article/view/308. Acesso em: 8 may. 2024.